Institution statistics

ABBVIE INC -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 19
As coordinator: 0
As participant: 19
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 8.290.694 0 1
2019 0 57.424.785 0 4
2018 0 15.639.743 0 3
2017 0 69.380.521 0 6
2016 0 36.752.571 0 5
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV8
NOVARTIS PHARMA8
PFIZER LIMITED7
UCB BIOPHARMA6
ELI LILLY AND COMPANY LIMITED5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
EUROPEAN PATIENTS' FORUM4
F HOFFMANNLA ROCHE4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT4
KATHOLIEKE UNIVERSITEIT LEUVEN4
NOVO NORDISK4
ASTRAZENECA AB3
BAYER AKTIENGESELLSCHAFT3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
SANOFIAVENTIS3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
TAKEDA DEVELOPMENT CENTRE EUROPE3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
BAYER2
BAYER PHARMA2
CELGENE MANAGEMENT SARL2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY2
MEDIZINISCHE UNIVERSITAET WIEN2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
ORION OYJ2
OSPEDALE PEDIATRICO BAMBINO GESU2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
SANOFIAVENTIS DEUTSCHLAND2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
STICHTING LAREB2
STIFTELSEN WHO COLLABORATING CENTRE FOR INTERNATIONAL DRUG MONITORING2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF NEWCASTLE UPON TYNE2
AB SCIEX PTE1
AGENZIA REGIONALE DI SANITA1
AMGEN1
ARLENDA1
ARTEEVO TECHNOLOGIES1
ASOCIACION PARKINSON MADRID1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
BARTS AND THE LONDON NHS TRUST1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOGEN IDEC LIMITED1
BIONOTUS1
BRISTOLMYERS SQUIBB COMPANY CORP1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BYTEFLIES1
CAMBRIDGE COGNITION LIMITED1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CERTARA UK LIMITED1
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY1
CHU HOPITAUX DE BORDEAUX1
CLARIVATE ANALYTICS LIMITED1
CONCENTRIS RESEARCH MANAGEMENT1
CONSIGLIO NAZIONALE DELLE RICERCHE1
COVANCE LABORATORIES1
CSL BEHRING1
DEHNE MATTHIAS1
DIMOKRITIO PANEPISTIMIO THRAKIS1
DREEM1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EISAI CO1
EKON MODELING SOFWARE SYSTEMS LTDEKON1
ELEVATE BV1
ELLEGAARD GOTTINGEN MINIPIGS AS1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
Constancy:

Total number of partners:346

Partner loyalty:
Frequent Partner: (> 2 projects): 88
Rare Partner: 258

Frequent / Rare Partner Ratio: 0.34

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69428
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52346
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis ArthritisHealparticipant3.297.27117
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-09-01WEB-RADR 2 WEB-RADR 2participant1.168.75011
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-03-01Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 IMPRiNDparticipant4.684.99819
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975 ADAPTEDparticipant3.510.00014
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-01-01Non-Noble Metal Catalysis - NoNoMeCat NoNoMeCatparticipant3.318.63415

Alias institution names:
  • ABBVIE
  • ABBVIE
  • ABBVIE DEUTSCHLAND GMBH & CO KG
  • ABBVIE INC

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum